Rett
This is a rebate from a tax incentive program, not a funding grant.
The amount of the rebate depends on how much the relevant company has expended. It's nice to have that tax rebate, but it's not the main game.
MSB has progressed a long way down the R&D stages, and with products at late stage FDA testing. Whereas companies receiving funding grants tend to be at the earlier stages of developing a product. IMO.
Ann: Mesoblast Receives $5.8m From Aus Govt For R&D, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 151980 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 29989 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |